Resmed

Forecast & Rating20 analysts currently cover Resmed, with about 40.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $247.56, about 11.2% upside from the current price of $222.72. Price targets range from $175.00 to $320.00 — a wide spread, showing clear disagreement over just how much Resmed can rise. Historically, about 60.0% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Resmed are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 17, 2026; for reference only and not investment advice.